Stuart McDougall: European Bioanalysis Forum Workshop Contribution
Stuart McDougall, Quotient Sciences' Principal Research Fellow of Bioanalytical Services, contributes to the European Bioanalysis Forum Workshop on the Harmonized Implementation of the ICH M10 Guideline.
John McDermott contributes to roundtable article with Drug Development & Delivery
John McDermott, Vice President of Scientific Consulting at Quotient Sciences, contributes to recent roundtable article with Drug Development & Delivery on 2023 trends.
Dr. Sarah Stevens Discusses Her Career in the Pharmaceutical Industry with Raman Sehgal on the Molecule to Market Podcast
Dr. Sarah Stevens, Senior Vice President & Head of Early Development & Late-Stage Commercial at Quotient Sciences, recently spoke with Raman Sehgal, host of the Molecule to Market podcast, about her career in the pharmaceutical industry and the differentiated drug development services that Quotient Sciences offers to customers.
Gareth Jenkins Contributes to Chemistry Today Panel Discussion on Flow Chemistry
Gareth Jenkins, VP Science and Technology, Candidate Development Services at Quotient Sciences, Contributes to Chemistry Today Panel Discussion on Flow Chemistry. Read it here.
Andy Lewis speaks about modified-release dosage forms in Drug Development & Delivery
Andy Lewis, Vice President, Pharmaceutical Sciences, has written an article for Drug Development & Delivery entitled, "Alternative Strategies for Development of Modified-Release Dosage Forms"
Quality Assurance & Compliance: Addressing and Overcoming the Ever-evolving Challenges in Drug Development and Manufacturing
PharmaTech Outlook Interview with Kimberly Paris, SVP & Chief compliance officer at Quotient Sciences: "Addressing and Overcoming the Ever-evolving Challenges in development"